Patent ID: 7943324

Claim:
A method of diagnosing or predicting the existence of endometriosis in a subject, comprising the steps of: a. determining an amount of macrophage chemoattractant protein-1 (MCP-1), and carcinoma antigen-125 (CA-125) in a biological sample of the subject; and b. comparing the amount of said MCP-1 and said CA-125 to a reference standard, whereby if the amount determined for said MCP-1 and said CA-125 falls above the cutoff concentration defined by the reference standard for said MCP-1 and said CA-125, then the subject is at a high risk of having endometriosis, wherein the cutoff concentration for said MCP-1 and said CA-125 is about 76.4 pg/ml and about 20.0 mIU/ml, respectively, and wherein the reference standard is derived from samples collected from a population that excludes stage I endometriosis.